ACURX PHARMACEUTICALS INC (ACXP)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.42+1.43%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ACXP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Selling, General & Admin | — | — | — | — | — | 0.2 | — |
| R&D Expenses | 2.1 | 1.8 | 5.4 | 6.0 | 4.8 | 2.0 | 2.2 |
| Operating Income | (7.7) | (8.1) | — | — | — | — | — |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 0.2 | 0.1 | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | 0.0 | — | 0.0 |
| Net Income | |||||||
| Net Income | (7.5) | (8.0) | (14.1) | (14.6) | (12.1) | (12.7) | (4.6) |
| Per Share | |||||||
| Basic EPS | (1.76) | (5.32) | (0.87) | (1.15) | (1.12) | (1.49) | (0.74) |
| Diluted EPS | (1.76) | (5.32) | (0.87) | (1.15) | (1.12) | (1.49) | (0.74) |
| Basic Weighted Avg Shares | 4.3 | 1.5 | 16.2 | 12.7 | 10.8 | 8.5 | 6.2 |
| Diluted Weighted Avg Shares | 4.3 | 1.5 | 16.2 | 12.7 | 10.8 | 8.5 | 6.2 |
| Supplemental | |||||||
| EBIT | (7.7) | (8.1) | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.